Supreme Cannabis Announces Financial Results for Q2 2021
Continued strong revenue growth and operational efficiency 2021 Second Quarter Highlights: Positive Adjusted EBITDA[1] of $3.6 million Consolidated net revenue of $18.3 million 54% net revenue growth quarter-over-quarter 52 active retail SKUs with 9 new SKUs introduced in Q2, with presence in all 10 provinces Completed fourth shipment of medical cannabis to Israel through its […]